Flexible 3D‑printed spine cages to improve spinal fusion
Investigating the effect of mechanical compliance of metamaterial interbody cages on spinal fusion progress in vivo
This project tests whether softer, 3D‑printed spinal cages help bone fuse faster and hold up better for adults who need interbody spinal fusion.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11259437 on NIH RePORTER |
What this research studies
Researchers will design new metamaterial interbody cages with tunable stiffness, porosity, and energy absorption using 3D printing. They will implant these compliant cages into ambulatory sheep and follow healing and implant settling over time to compare fusion progress across different cage designs. The team will measure bone formation, load‑sharing through the interbody space, and any subsidence of the spinal segments across a full range of motion. Findings in the animal model will guide whether these more flexible cages could be promising for future human use.
Who could benefit from this research
Good fit: Adults who are candidates for interbody spinal fusion for conditions like degenerative disc disease or spinal instability would be the likely patients for future clinical use.
Not a fit: People who are not candidates for interbody fusion (for example those with active spinal infection, severe osteoporosis, or other contraindications to surgery) would likely not benefit from this technology.
Why it matters
Potential benefit: If successful, these flexible cages could lead to faster, more reliable spinal fusion with fewer complications such as implant sinking or stress shielding.
How similar studies have performed: This metamaterial, compliance‑focused approach is novel and has promising rationale from prior lab and animal work on load‑sharing, but it has not yet been proven in humans.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Alavi, Amir — University of Pittsburgh at Pittsburgh
- Study coordinator: Alavi, Amir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.